Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1374079 | Bioorganic & Medicinal Chemistry Letters | 2012 | 5 Pages |
Abstract
A novel series of benzenesulfonanilide derivatives of 11β-HSD1 inhibitors were identified via modification of the sulfonamide core of the arylsulfonylpiperazine lead structures. The synthesis, in vitro biological evaluation, and structure–activity relationship of these compounds are presented. Optimization of this series rapidly resulted in the discovery of compounds (S)-10 and (S)-23 (11β-HSD1 SPA IC50 = 1.8 and 1.4 nM, respectively).
Graphical abstractThe discovery and optimization of a benzenesulfonanilide series of 11β-HSD1 inhibitors is reported.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Yosup Rew, Michael DeGraffenreid, Xiao He, Juan C. Jaen, Dustin L. McMinn, Daqing Sun, Hua Tu, Stefania Ursu, Jay P. Powers,